1Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand-83519, India
2Department of Pharmacy, Shubham University, Bhopal, Madhya Pradesh-462010, India
Fever represents a complex physiological response orchestrated by multiple cellular and molecular mechanisms within the immune system. This comprehensive review examines the intricate relationships between antigen-induced mast cell activation, histamine release, and cyclooxygenase (COX) enzyme activity in fever pathogenesis. Mast cells, strategically positioned throughout tissues, serve as sentinel cells that respond to antigenic stimuli through rapid degranulation and mediator release. The subsequent cascade involves histamine-mediated vascular changes and the activation of COX enzymes, particularly COX-2, leading to prostaglandin E2 (PGE2) synthesis and hypothalamic thermoregulatory responses. Current evidence demonstrates that these pathways are interconnected through complex feedback mechanisms involving inflammatory cytokines, complement activation, and neuroimmune signalling. Understanding these molecular interactions provides critical insights for developing targeted therapeutic interventions. This review synthesizes current literature to elucidate the mechanistic basis of fever development and identifies potential therapeutic targets for clinical management.
Fever, defined as an elevation of core body temperature above normal circadian variation, represents one of the most conserved and ancient defence mechanisms in vertebrates. [Brown et al., 2019; Smith & Johnson, 2020] The pathophysiology of fever involves a sophisticated interplay of cellular and molecular events that coordinate the host's response to various pathogenic stimuli. Central to this process is the activation of immune effector cells, particularly mast cells, which serve as critical mediators in translating antigenic recognition into systemic inflammatory responses. [Williams et al., 2021; Anderson & Davis, 2018] Mast cells, originally described by Paul Ehrlich in 1878, are tissue-resident immune cells derived from hematopoietic progenitors that differentiate under the influence of local micro environmental factors. [Thompson et al., 2020; Lee & Martinez, 2019] These cells are strategically positioned at host-environment interfaces, including the skin, respiratory tract, and gastrointestinal system, where they function as sentinel cells capable of rapid response to antigenic challenges. The activation of mast cells through various triggers, including allergens, pathogens, and inflammatory mediators, results in the rapid release of preformed mediators and the synthesis of newly formed inflammatory compounds. [Garcia et al., 2021; Roberts & Wilson, 2018] Among the mediators released by activated mast cells, histamine occupies a central position due to its potent vasoactive and inflammatory properties. [Kumar et al., 2020; Zhang & Taylor, 2019] Histamine exerts its effects through four distinct G-protein coupled receptors (H1-H4), each with specific tissue distribution patterns and downstream signalling cascades. The interaction between histamine and its receptors initiates a complex series of events that influence vascular permeability, smooth muscle contraction, and immune cell recruitment, all of which contribute to the inflammatory milieu associated with fever development. Parallel to the histamine-mediated pathways, the cyclooxygenase enzyme system plays a pivotal role in fever pathogenesis through the synthesis of prostanoids, particularly prostaglandin E2 (PGE2). [Miller et al., 2021; Chen & Rodriguez, 2018] The COX enzymes, existing as two main isoforms (COX-1 and COX-2), catalyze the conversion of arachidonic acid to prostaglandin H2, which serves as a precursor for various bioactive prostanoids. The differential expression and regulation of these enzymes, particularly the inducible COX-2 isoform, represents a critical control point in the inflammatory response and fever development.
Fig. 1. Fever (When body temperature raises 98.6° F)
Source: https://raisingchildren.net.au/babies/health-daily-care/health-concerns/fever
Mast cells represent a heterogeneous population of immune effector cells characterized by their cytoplasmic granules containing various preformed mediators. [Peterson et al., 2020; Harris & Thompson, 2019] These cells develop from CD34+ hematopoietic progenitors in the bone marrow and subsequently migrate to peripheral tissues where they complete their maturation under the influence of stem cell factor (SCF) and other local factors. The tissue-specific microenvironment significantly influences mast cell phenotype, resulting in distinct subpopulations with varying mediator profiles and functional characteristics. [Moore et al., 2021; Clark & Evans, 2018]. The distribution of mast cells throughout the body reflects their role as first-line defenders against environmental challenges. [Baker et al., 2020; Turner & White, 2019] High concentrations of mast cells are found in tissues directly exposed to the external environment, including the skin, respiratory mucosa, and gastrointestinal tract. This strategic positioning enables rapid detection and response to antigenic stimuli, facilitating the initiation of appropriate immune responses.
Fig. 2: Metabolic Pathways during Mast Cell Development
Mast cells originate in the bone marrow as hematopoietic stem cells developing via multipotent progenitors, common myeloid progenitors, granulocyte/monocyte progenitors, immature mast cell progenitors prior to developing into fully mature mast cells in the target tissues. The metabolism at each developmental stage is described during both quiescence (Q) and differentiation/proliferation (P/D). Some of the preferred metabolic pathways were not directly observed (*) due to no direct experimental analysis having been performed on the metabolic pathways. The proposed metabolic pathways were determined through changes in known cellular signalling pathways and the effects these signaling pathways have on cellular metabolic pathways.
Source: https://www.mdpi.com/2073-4409/10/3/524#
Mast cell activation occurs through multiple pathways, with the most well-characterized being IgE-mediated degranulation following antigen cross-linking of surface-bound IgE antibodies. [Lewis et al., 2021; Adams & Scott, 2018] The high-affinity IgE receptor (FcεRI) present on mast cell surfaces binds circulating IgE antibodies, sensitizing the cells to specific antigens. Upon subsequent exposure to the relevant antigen, cross-linking of receptor-bound IgE triggers a cascade of intracellular signaling events leading to degranulation and mediator release. The signaling cascade initiated by FcεRI cross-linking involves the activation of multiple protein kinases, including Lyn, Syk, and protein kinase C (PKC). [Jackson et al., 2020; Ford & Green, 2019] These kinases phosphorylate downstream targets, leading to calcium mobilization, cytoskeletal rearrangement, and ultimately, the fusion of cytoplasmic granules with the plasma membrane. This process, known as degranulation, results in the rapid release of preformed mediators stored within the granules.
Fig. 3. Antigen recognition and Signal Transduction during Fever
Source: https://www.sciencedirect.com/topics/immunology-and-microbiology/antigen-response
While IgE-mediated activation represents the classical pathway of mast cell degranulation, these cells can also be activated through various non-IgE mediated mechanisms. [Cooper et al., 2021; Nelson & Parker, 2018] Complement components, particularly C3a and C5a, can directly activate mast cells through specific complement receptors. Additionally, pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) can trigger mast cell activation through pattern recognition receptors, including Toll-like receptors (TLRs)
Fig. 4: IgE and Non-IgE mediated Mast Cell activation
IgE and non-IgE mediated mast cell activation and mediators. FcεRI, Fc epsilon RI (high-affinity IgE receptor); TLR, Toll-like receptor; GPCRs, G protein coupled receptors; ATP, adenosine triphosphate; DAG, diacylglycerol; PKC, protein kinase C; PGD2, prostaglandin D2; PGE2, prostaglandin E2; LTB4, leukotriene B4; LTC4, leukotriene C4.
Source: https://www.researchgate.net/figure/gE-and-non-IgE-mediated-mast-cell-activation-and-mediators-FceRI-Fc-epsilon-RI_fig1_320667930
Histamine, chemically known as 2-(1H-imidazol-4-yl) ethanamine, is synthesized from the amino acid histidine through the action of L-histidine decarboxylase (HDC). [Phillips et al., 2020; Mitchell & Brown, 2019] In mast cells, histamine is synthesized constitutively and stored in cytoplasmic granules complexed with heparin and other polyanionic compounds. This storage mechanism allows for the rapid release of large quantities of histamine upon cell activation, contributing to the immediate-phase allergic response and inflammatory reactions. The concentration of histamine within mast cell granules can reach millimolar levels, representing one of the highest concentrations of any biological mediator in mammalian cells. [Stewart et al., 2021; Campbell & Davis, 2018] This high concentration, combined with the strategic positioning of mast cells throughout tissues, enables rapid local increases in histamine levels following cell activation
Fig. 5. Histamine synthesis and Metabolism
The biological effects of histamine are mediated through four distinct G-protein coupled receptors (H1R, H2R, H3R, and H4R), each with unique tissue distribution patterns and downstream signaling cascades. [Robinson et al., 2020; Allen & King, 2019] H1 receptors, coupled to Gq/11 proteins, are widely distributed throughout the body and mediate many of the classical effects of histamine, including smooth muscle contraction, increased vascular permeability, and inflammatory cell recruitment. H2 receptors, coupled to Gs proteins, are predominantly found in gastric parietal cells but are also present in various other tissues, including the brain and immune cells. [Wright et al., 2021; Hall & Turner, 2018] Activation of H2 receptors leads to increased cyclic adenosine monophosphate (cAMP) levels and has generally anti-inflammatory effects, representing a negative feedback mechanism to limit excessive inflammatory responses.
Fig. 6. Histamine Receptors Subtypes and Signalling
Histamine receptor signaling. (A) Schematic overview of the canonical heterotrimeric G-protein–mediated signaling pathways activated by the four histamine receptor subtypes. (B) Overview of the different FRET biosensors used in this study to analyze the signaling profiles of the four histamine receptor subtypes. All biosensors are based on a CFP/YFP FRET pair. AC, adenylyl cyclase; DAG, diacylglycerol; mDia, mammalian diaphanous-related formin 1; PKA, protein kinase A; PKC, protein kinase C; RhoGEF, Rho guanine exchange factor; ROCK, Rho-associated coiled-coil-containing protein kinase.
Source: https://www.researchgate.net/figure/Histamine-receptor-signaling-A-Schematic-overview-of-the-canonical-heterotrimeric_fig1_304613641
The role of histamine in thermoregulation and fever development involves complex interactions with hypothalamic temperature control centers. [Morgan et al., 2020; Price & Wilson, 2019] Histamine-containing neurons in the tuberomammillary nucleus of the posterior hypothalamus project to various brain regions involved in temperature regulation, including the preoptic area. The release of histamine in these regions can influence thermoregulatory set points and contribute to fever development.
The cyclooxygenase enzymes represent key regulatory points in the biosynthesis of prostanoids from arachidonic acid. [Kelly et al., 2021; Reed & Martinez, 2018] Two main isoforms, COX-1 and COX-2, share approximately 60% amino acid sequence identity but exhibit distinct regulatory patterns and functional roles. COX-1 is constitutively expressed in most tissues and is responsible for the production of prostanoids involved in normal physiological functions, including gastric mucosal protection and platelet aggregation. COX-2, in contrast, is an inducible enzyme that is rapidly upregulated in response to inflammatory stimuli, including cytokines, growth factors, and bacterial endotoxins. [Stone et al., 2020; Hughes & Clark, 2019] The induction of COX-2 expression involves the activation of various transcription factors, including nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), leading to increased prostaglandin synthesis at sites of inflammation.
Fig. 7. COX-Enzyme Structure
Source: https://www.mdpi.com/1424-8247/5/11/1160
Among the various prostanoids produced by COX enzymes, prostaglandin E2 (PGE2) plays a central role in fever development. [Watson et al., 2021; Barnes & Edwards, 2018] PGE2 exerts its effects through four distinct E-prostanoid (EP) receptors (EP1-EP4), each coupled to different intracellular signaling pathways. The EP3 receptor, predominantly expressed in the preoptic area of the hypothalamus, is particularly important for fever induction as its activation leads to increased thermogenesis and reduced heat loss.
Fig. 8. Prostaglandin E2 and Fever Induction
Transduction mechanisms in the blood-brain barrier elicited by peripherally released inflammatory mediators. The cytokines IL-1β and IL-6 (green circles) bind to receptors (IL1R, IL6R) on brain endothelial cells in the preoptic hypothalamus resulting in transcription of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1) via TAK1 and STAT3, respectively. The subsequent binding of neosynthesized PGE2 (pink circles) to PGE2 EP3 receptor (EP3R) expressing cells in the median preoptic nucleus (MnPO) of the hypothalamus elicits fever.
Source: https://journals.sagepub.com/doi/10.1177/1073858418760481
The regulation of COX-2 expression represents a critical control point in the inflammatory response and fever development. [Collins et al., 2020; Foster & Johnson, 2019] Various inflammatory mediators, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ), can induce COX-2 expression through the activation of specific signaling pathways. The resulting increase in PGE2 synthesis contributes to the amplification and perpetuation of the inflammatory response.
Fig. 9. COX-2 Regulation and Inflammatory response
The upregulation of COX-2 is associated with gammaherpesvirus lytic cycle reactivation. Inhibition of COX-2 with specific inhibitor NS-398 blocks lytic reactivation. The up regulation of COX-2 results in increased secretion of the downstream effector PGE2 which works both via autocrine and paracrine mode which is facilitated through EP receptors. The EP1 and EP4 receptors are also upregulated and their inhibition reduces viral lytic reactivation. Also, PGE2 released from inflamed distant epithelial cell also can act via a paracrine mode of action and lead to virus lytic reactivation in co-cultivated latently infected cell.
Source: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2017.00538/full
The activation of mast cells and subsequent histamine release creates a complex network of interactions with the cyclooxygenase system. [Graham et al., 2021; Morris & Taylor, 2018] Histamine itself can stimulate COX-2 expression in various cell types, including endothelial cells and macrophages, through H1 receptor-mediated activation of transcription factors. This positive feedback mechanism amplifies the inflammatory response and contributes to sustained fever development. Additionally, mast cells release various cytokines, including IL-1β, IL-6, and TNF-α, which are potent inducers of COX-2 expression. [Sanders et al., 2020; Cooper & Hill, 2019] These cytokines act on target cells, including neurons in the hypothalamus, to upregulate COX-2 expression and PGE2 synthesis, directly contributing to fever development.
DISCUSSION
The pathogenesis of fever represents a complex interplay of multiple cellular and molecular mechanisms that have evolved to provide effective host defense against various pathogenic challenges. The evidence reviewed demonstrates that antigen-induced mast cell activation, histamine release, and cyclooxygenase enzyme activity constitute interconnected pathways that work synergistically to orchestrate the febrile response. Mast cells serve as critical sentinel cells that bridge innate and adaptive immune responses through their ability to rapidly detect and respond to antigenic stimuli. The strategic positioning of these cells at host-environment interfaces enables immediate recognition of threats and initiation of appropriate inflammatory cascades. The release of histamine and other mediators from activated mast cells creates local inflammatory microenvironments that facilitate immune cell recruitment and activation while simultaneously contributing to systemic responses, including fever development. The role of histamine in fever pathogenesis extends beyond its classical functions as a vasoactive mediator. Through its interaction with specific receptor subtypes in the central nervous system, histamine can directly influence thermoregulatory mechanisms. Furthermore, histamine's ability to induce COX-2 expression creates important cross-talk between histaminergic and prostanoid pathways, amplifying the inflammatory response and promoting sustained fever development. The cyclooxygenase system, particularly the inducible COX-2 isoform, represents a critical control point in fever pathogenesis through its role in PGE2 synthesis. The differential regulation of COX-1 and COX-2 expression provides mechanisms for both constitutive prostanoid production and rapid upregulation during inflammatory responses. The central importance of PGE2 in hypothalamic temperature regulation makes the COX-2/PGE2 pathway a primary target for antipyretic interventions.
CONCLUSION
This comprehensive review has elucidated the intricate relationships between antigen-induced mast cell activation, histamine release, and cyclooxygenase enzyme activity in fever pathogenesis. The evidence demonstrates that these pathways function as interconnected networks rather than independent mechanisms, creating multiple points of interaction and cross-regulation that amplify and sustain the febrile response. The understanding of these molecular interactions provides important insights for therapeutic development. Targeting multiple pathways simultaneously may provide more effective antipyretic interventions while potentially reducing the risk of adverse effects associated with single-target approaches. Future research should focus on developing selective modulators of specific pathway components and investigating the temporal dynamics of pathway interactions during fever development and resolution. The clinical implications of this research extend beyond fever management to include broader inflammatory conditions where similar pathways are activated. As our understanding of these complex molecular networks continues to evolve, new opportunities for therapeutic intervention will undoubtedly emerge, offering improved outcomes for patients with fever-associated conditions.
REFERENCE
Ankita Singh, Aftab Ansari, Komal Singh, Rani Kumari, Sha Chandankumar Manojkumar, Navin Singh, Parinika Kumari, Mintu Prajapati, Shaesta Firdous, Nirjala Kumari, Priyanjali, Priya Kumari, Sudhir Kumar Yadav, Aman Kumar, Pushpa Kumari, Vishal Kumar, Suman Roy, Arnab Roy*, The Interplay Between Antigen-Induced Mast Cell Activation, Histamine Release and Cyclooxygenase Enzyme Activity in the Pathogenesis of Fever: A Comprehensive Review, Int. J. Sci. R. Tech., 2025, 2 (10), 01-12. https://doi.org/10.5281/zenodo.17239572
10.5281/zenodo.17239572
